Literature DB >> 19762898

Evaluation and treatment of inflammatory myopathies.

A A Amato1, R J Barohn.   

Abstract

The major types of idiopathic inflammatory myopathy include dermatomyositis (DM), polymyositis (PM), inclusion body myositis (IBM) and immune mediated necrotising myopathy (NM). These myositides appear clinically, histologically and pathogenically distinct. DM, PM and immune mediated NM are responsive to immunosuppressive therapy, in contrast with IBM which is generally refractory to therapy. Greater understanding of the pathogenic bases of these disorders should hopefully lead to better treatment. We need well designed, prospective, double blind, placebo controlled trials in order to determine the best therapeutic options for these different disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19762898     DOI: 10.1136/jnnp.2008.169375

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  25 in total

1.  Inflammatory myopathies.

Authors:  B Jane Distad; Anthony A Amato; Michael D Weiss
Journal:  Curr Treat Options Neurol       Date:  2011-04       Impact factor: 3.598

Review 2.  Neurogenic changes in the upper airway of obstructive sleep apnoea.

Authors:  Julian P Saboisky; Jane E Butler; Billy L Luu; Simon C Gandevia
Journal:  Curr Neurol Neurosci Rep       Date:  2015-04       Impact factor: 5.081

Review 3.  Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.

Authors:  Pari Basharat; Lisa Christopher-Stine
Journal:  Curr Rheumatol Rep       Date:  2015-12       Impact factor: 4.592

Review 4.  [Standard treatment for myositis and muscular dystrophies].

Authors:  J Schmidt; M Vorgerd
Journal:  Nervenarzt       Date:  2011-06       Impact factor: 1.214

Review 5.  [Myositides: What is the current situation?].

Authors:  K M Rösler; O Scheidegger
Journal:  Z Rheumatol       Date:  2015-08       Impact factor: 1.372

6.  A randomized, pilot trial of etanercept in dermatomyositis.

Authors: 
Journal:  Ann Neurol       Date:  2011-06-17       Impact factor: 10.422

7.  Persisting weakness after withdrawal of a statin.

Authors:  Åse Mygland; Unn Ljøstad; Bård Kronen Krossnes
Journal:  BMJ Case Rep       Date:  2014-04-08

8.  Disease course and therapeutic approach in dermatomyositis: A four-center retrospective study of 100 patients.

Authors:  Nicholas E Johnson; W David Arnold; Donald Hebert; Kelly Gwathmey; Mazen M Dimachkie; Richard J Barohn; April L McVey; Mamatha Pasnoor; Anthony A Amato; Michael P McDermott; John Kissel; Chad R Heatwole
Journal:  Neuromuscul Disord       Date:  2015-05-07       Impact factor: 4.296

9.  [Severe dysphagia and erythrodermia in a 59-year-old man].

Authors:  M A Zuber; M Kouba; S E Rudolph; M Weller; P Hrdlicka
Journal:  Internist (Berl)       Date:  2013-03       Impact factor: 0.743

Review 10.  Electrodiagnostic evaluation of myopathies.

Authors:  Sabrina Paganoni; Anthony Amato
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-10-16       Impact factor: 1.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.